Christopher Yuskaitis, MD, PhD
Education
BS, University of Virginia, 2002
Charlottesville, VA
MD, PhD, University of Alabama at Birmingham, 2011
Birmingham, AL
Internship and Pediatrics Residency, Boston Combined Residency Program, 2013
Boston, MA
Child Neurology Residency, Boston Children's Hospital, 2016
Boston, MA
Neurogenetics Fellowship, Boston Children's Hospital, 2016
Boston, MA
Post-Lab Work
Associate Medical Director, Takeda (2023 - )
Related Publications
- A mouse model of DEPDC5-related epilepsy: Neuronal loss of Depdc5 causes dysplastic and ectopic neurons, increased mTOR signaling, and seizure susceptibility
- Chronic mTORC1 inhibition rescues behavioral and biochemical deficits resulting from neuronal Depdc5 loss in mice
- Defining the clinical, molecular and imaging spectrum of adaptor protein complex 4-associated hereditary spastic paraplegia
- Factors influencing the acute pentylenetetrazole-induced seizure paradigm and a literature review
- The non-essential TSC complex component TBC1D7 restricts tissue mTORC1 signaling and brain and neuron growth